Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.6780
+0.0174 (2.63%)
At close: Oct 2, 2026, 4:00 PM EDT
0.6612
-0.0168 (-2.48%)
After-hours: Oct 2, 2026, 4:10 PM EDT
Envoy Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 |
| 52 | 61 | 51 | 19 | 18 | 30 | 28 | 29 | 64 | 46 | 77 | 35 | 137 | 1,425 | - | - | - | - | - | |
Market Cap Growth (YoY) | 184.18% | 101.06% | 84.43% | -34.26% | -71.01% | -34.53% | -63.82% | -18.21% | -53.55% | -96.75% | - | - | - | - | - | - | - | - | - |
Enterprise Value | 33 | 37 | 48 | 16 | 42 | 49 | 42 | 40 | 71 | 47 | 70 | 29 | 214 | 1,490 | - | - | - | - | - |
Last Close Price | 0.68 | 0.79 | 0.67 | 0.66 | 0.78 | 1.42 | 1.30 | 1.43 | 3.25 | 2.36 | 3.92 | 1.81 | 7.01 | 10.24 | 10.05 | 10.02 | 9.82 | 9.80 | 9.77 |
Price Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | - | - | - | - | - | - | - | - | -3.74 | - | - | - | - | - | - |
PS Ratio | 252.84 | 294.15 | 218.52 | 78.97 | 88.80 | 136.41 | 130.78 | 128.67 | 229.14 | 153.17 | 258.03 | 112.02 | 569.06 | 6536.43 | - | - | - | - | - |
PB Ratio | 14.17 | 16.48 | 4.85 | -1.62 | -2.45 | -1.01 | -1.14 | -1.54 | -3.44 | -3.73 | -10.34 | -19.93 | 28.66 | -23.87 | - | - | - | - | - |
P/TBV Ratio | 14.17 | 16.48 | 4.85 | - | - | - | - | - | - | - | - | - | 28.66 | - | - | - | - | - | - |
P/FCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | -16.14 | - | - | - | - | - | - |
P/OCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | -16.47 | - | - | - | - | - | - |
EV Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 161.69 | 176.46 | 206.47 | 68.14 | 202.00 | 220.72 | 197.65 | 178.38 | 253.75 | 154.53 | 234.97 | 90.34 | 886.57 | 6833.68 | - | - | - | - | - |
EV/FCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | -25.14 | - | - | - | - | - | - |
Financial Efficiency
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.22 | 0.22 | 0.08 | -0.08 | -0.13 | -0.97 | -0.99 | -1.04 | -0.84 | -0.69 | -0.72 | -0.32 | 0.12 | -0.95 | -0.97 | -0.95 | - | - | -0.94 |
Debt / FCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | -0.07 | - | - | - | - | - | - |
Net Debt / Equity Ratio | -5.11 | -5.11 | -2.31 | 0.24 | 0.35 | -0.79 | -0.77 | -0.75 | -0.60 | -0.55 | -0.05 | 2.06 | -1.43 | -0.95 | -0.94 | -0.95 | - | - | -0.89 |
Net Debt / EBITDA Ratio | 0.82 | 0.82 | 1.08 | 0.13 | 0.13 | -1.21 | -0.97 | -0.74 | -0.53 | -0.35 | -0.02 | 0.20 | 0.48 | -4.40 | -4.24 | -3.98 | - | - | -12.44 |
Net Debt / FCF Ratio | 0.87 | 0.87 | 1.18 | 0.15 | 0.15 | -1.47 | -1.10 | -0.75 | -0.44 | -0.32 | -0.02 | 0.21 | 0.81 | -4.68 | -4.44 | -3.81 | - | - | -11.16 |
Asset Turnover | 0.01 | 0.01 | 0.04 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.08 | 0.10 | - | - | - | - | |
Inventory Turnover | 0.52 | 0.73 | 0.83 | 0.05 | 0.50 | 0.58 | 0.54 | 0.38 | 0.46 | 0.65 | 0.43 | 0.67 | 0.56 | 0.50 | 0.54 | - | - | - | - |
Quick Ratio | 1.56 | 1.56 | 2.07 | 0.33 | 0.40 | 0.67 | 0.71 | 0.84 | 0.51 | 0.24 | 0.74 | 0.61 | 0.67 | 0.03 | 0.34 | 0.09 | - | - | - |
Current Ratio | 1.74 | 1.74 | 2.27 | 0.54 | 0.64 | 0.94 | 1.09 | 1.18 | 0.79 | 0.62 | 1.11 | 1.02 | 1.60 | 0.41 | 0.76 | 0.65 | - | - | - |
Return on Equity (ROE) | -335.93% | - | - | - | - | - | - | - | - | - | -1301.00% | - | - | - | - | - | - | - | |
Return on Assets (ROA) | -51.78% | -77.63% | -185.05% | -157.84% | -124.97% | -116.48% | -108.65% | -154.08% | -159.43% | -145.78% | -114.00% | -71.09% | -365.12% | -309.20% | - | - | - | - | |
Return on Capital Employed (ROCE) | -207.10% | -207.10% | -130.20% | 735.00% | 2532.10% | -1036.70% | -698.20% | -481.40% | -6635.00% | 1502.20% | -1312.10% | -1862.00% | -170.60% | 812.60% | -10159.00% | -23529.70% | - | - | - |
Yields
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 |
Earnings Yield | -54.37% | -38.43% | -45.19% | -124.83% | -117.97% | -70.22% | -70.42% | -71.83% | -33.08% | -29.29% | -29.81% | -84.28% | -26.55% | -2.76% | - | - | - | - | - |
FCF Yield | -41.48% | -35.66% | -40.50% | -96.58% | -92.48% | -52.79% | -61.18% | -65.39% | -40.09% | -45.97% | -25.93% | -48.72% | -6.20% | -0.85% | - | - | - | - | - |
Buyback Yield / Dilution | -177.04% | -386.53% | -223.23% | -47.17% | -17.38% | -14.97% | -14.66% | -3.34% | -65.99% | -83.75% | -83.75% | -84.93% | -10.79% | 92.73% | 92.73% | - | - | - | - |